https://www.selleckchem.com/products/tram-34.html
RESULTS Over half of participants were Hispanic (51.2%), with 25.3% being non-Hispanic black and 17.9% non-Hispanic white. Two thirds were male, and 54.9% reported injection as method of drug use. One hundred thirty-four participants (82.7%) completed the 1-month assessment. Participants in the treatment arm were more likely to report having received both test results than those in the control arm (69% vs. 19%, P less then 0.001). Seven participants in the treatment arm received a preliminary new HCV diagnosis, versus 1 in the control a